Anson Funds Management LP Allakos Inc. Transaction History

Anson Funds Management LP

  • $839 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.02 - $6.12 $106,328 - $215,472
35,208 New
35,208 $215,000
Q1 2022

May 12, 2022
SELL
$5.08 - $9.81 $2.31 Million - $4.46 Million
-454,496 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.55 - $111.89 $3.89 Million - $50.9 Million
454,496 New
454,496 $4.45 Million

Others Institutions Holding ALLK

# of Institutions
82
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $91.5M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email